Overview

Spironolactone for Paroxysmal Atrial Fibrillation

Status:
Unknown status
Trial end date:
2011-03-01
Target enrollment:
0
Participant gender:
All
Summary
To determine whether or not spironolactone can prevent or delay the occurrence of atrial fibrillation.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Taichung Veterans General Hospital
Treatments:
Spironolactone
Criteria
Inclusion criteria:

1. 18 to 80 Y/O,

2. Paroxysmal AF.

Exclusion criteria:

1. GPT>100 IU/L or tota bilirubin >2 mg/dl;

2. Creatinine > 2 mg/dl;

3. Serum potassium >= 5 mM;

4. Serum sodium <=130 mM;

5. Uric acid > 10 mg/dl。